Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Completed 13Unknown 3Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Non-Erosive Reflux Disease 1Gastroesophageal Reflux 1Colorectal Neoplasms 1Barrett Esophagus 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Rabeprazole × Clear all
NCT04254471 2020-02-05

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Haihe Biopharma Co., Ltd.

Phase 2/3 Unknown
313 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03260179 2017-08-24

Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

Haihe Biopharma Co., Ltd.

Phase 1 Unknown
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02149914 2014-11-20

The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

Taichung Tzu Chi Hospital

Phase NA Unknown
120 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡